Penn Mutual Asset Management’s Tectonic Therapeutic TECX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2022
Q4
Sell
-3,109
Closed -$24K 73
2022
Q3
$24K Hold
3,109
0.03% 63
2022
Q2
$34K Hold
3,109
0.05% 53
2022
Q1
$49K Buy
+3,109
New +$64.2K 0.06% 52
2021
Q3
Sell
-2,176
Closed -$232K 88
2021
Q2
$232K Buy
+2,176
New +$258K 0.29% 52
2021
Q1
Sell
-3,109
Closed -$520K 85
2020
Q4
$520K Hold
3,109
0.46% 29
2020
Q3
$486K Hold
3,109
0.69% 22
2020
Q2
$651K Hold
3,109
0.67% 25
2020
Q1
$580K Buy
+3,109
New +$732K 0.42% 24

Other funds holding TECX

Penn Mutual Asset Management's TECX Position: Q4 2022 in Review

Penn Mutual Asset Management sold out of Tectonic Therapeutic (TECX) in Q4 2022, closing a stake of 3,109 shares — an estimated $24K sold.

Penn Mutual Asset Management first reported a position in TECX in Q1 2020 and held it in 8 quarters. The position peaked at $651K in Q2 2020. 45 funds tracked by Wall St. Rank hold TECX as of Q4 2022.

  • Penn Mutual Asset Management reported no remaining Tectonic Therapeutic position as of Q4 2022 after selling out during the quarter.
  • Penn Mutual Asset Management sold 3,109 Tectonic Therapeutic shares in Q4 2022, an estimated $24K.
  • Penn Mutual Asset Management first reported a position in Tectonic Therapeutic in Q1 2020 and held it in 8 quarters.
  • Penn Mutual Asset Management's Tectonic Therapeutic position peaked at $651K in Q2 2020.
  • 45 funds tracked by Wall St. Rank held Tectonic Therapeutic as of Q4 2022.

Based on Penn Mutual Asset Management's 13F filing for Q4 2022, filed 13 Feb 2023.